Trials / Sponsors / Olivia Newton-John Cancer Research Institute
Olivia Newton-John Cancer Research Institute
Academic / Other · 9 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Active Not Recruiting | Treatment Of Newly-diagnosed Follicular Lymphoma With CELMoD Golcadomide, Rituximab +/- Nivolumab. Follicular Lymphoma Stage II, Follicular Lymphoma Stage III, Follicular Lymphoma Stage IV | Phase 2 | 2023-08-31 |
| Unknown | A Prospective, Multi-Centre Trial of TKI Redifferentiation Therapy in Patients With RAIR Thyroid Cancer (I-FIR Thyroid Cancer | Phase 2 | 2022-07-14 |
| Active Not Recruiting | Frontline Treatment of Follicular Lymphoma With AtezolizUmab and Obinutuzumab With and Without RadiOtherapy Follicular Lymphoma | Phase 2 | 2021-08-17 |
| Active Not Recruiting | Combination Immunotherapy in Rare Cancers Under InvesTigation Advanced Biliary Tract Cancer, Neuroendocrine Tumors, Female Reproductive System Neoplasm | Phase 2 | 2021-08-03 |
| Terminated | Bioimaging Study of 89Zr-M7824 in NSCLC Non-Small Cell Lung Cancer | Phase 1 / Phase 2 | 2020-06-01 |
| Unknown | Medical Imaging of Cachexia Cancer Cachexia | N/A | 2019-03-28 |
| Completed | A Trial of KB004 in Patients With Glioblastoma Glioblastoma | Phase 1 | 2017-12-05 |
| Completed | A Phase II Trial of Ipilimumab and Nivolumab for the Treatment of Rare Cancers Gastrointestinal Cancer, Neuroendocrine Tumours, Malignant Female Reproductive System Neoplasm | Phase 2 | 2017-08-22 |
| Unknown | Pembrolizumab + CVA21 in Advanced NSCLC Non-Small Cell Lung Cancer | Phase 1 | 2017-08-09 |